Study on Regenerative Medicine for Severe Ocukar Surface Diseases
全件表示
論文 (162件):
Tatsuya Nakagawa, Naoki Okumura, Masaya Ikegawa, Yumiko Toyama, Takashi Nirasawa, Frederic Mascarelli, Hanielle Vaitinadapoule, Ines Aouimeur, Zhiguo He, Philippe Gain, et al. Shotgun proteomics identification of proteins expressed in the Descemet's membrane of patients with Fuchs endothelial corneal dystrophy. Scientific reports. 2023. 13. 1. 10401-10401
Hidenobu Tanihara, Tetsuya Yamamoto, Makoto Aihara, Noriko Koizumi, Hiroomi Minami, Satoshi Kojima, Tomoyuki Isobe, Mizuho Kanazawa, Hideki Suganami. Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine. Advances in therapy. 2023
Yasufumi Tomioka, Koji Kitazawa, Hideki Fukuoka, Morio Ueno, Noriko Koizumi, Chie Sotozono, Shigeru Kinoshita. Twelve-year outcome of Rho-associated protein kinase inhibitor eye drop treatment for Fuchs endothelial corneal dystrophy: A case study. American journal of ophthalmology case reports. 2023. 30. 101839-101839
Tatsuya Nakagawa, Yuichi Tokuda, Masakazu Nakano, Yuya Komori, Naoya Hanada, Theofilos Tourtas, Ursula Schlötzer-Schrehardt, Friedrich Kruse, Kei Tashiro, Noriko Koizumi, et al. RNA-Seq-Based Transcriptome Analysis of Corneal Endothelial Cells Derived from Patients with Fuchs Endothelial Corneal Dystrophy. 2022
Kohei Toh, Kosuke Nishio, Reiko Nakagawa, Syusuke Egoshi, Masahiro Abo, Amelie Perron, Shin-Ichi Sato, Naoki Okumura, Noriko Koizumi, Kosuke Dodo, et al. Chemoproteomic Identification of Blue-Light-Damaged Proteins. Journal of the American Chemical Society. 2022. 144. 44. 20171-20176